Business Description
Extrawell Pharmaceutical Holdings Ltd
NAICS : 325412
ISIN : BMG3285Q1134
Compare
Compare
Traded in other countries / regions
00858.Hong Kong IPO Date
1999-10-03Description
Extrawell Pharmaceutical Holdings Ltd is an investment holding company. The company's operating segment includes Manufacturing; Trading and Gene Development. It generates maximum revenue from the Manufacturing segment. The manufacturing segment is engaged in the development, manufacture, and sales of pharmaceutical products. Its trading segment is engaged in the marketing and distribution of imported pharmaceutical products. The gene development segment is engaged in the commercial exploitation and development of genome-related technology. Geographically, it derives a majority of its revenue from China.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.82 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-Equity | 0.11 | |||||
| Debt-to-EBITDA | -0.83 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.35 | |||||
| Beneish M-Score | -1.86 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -2.9 | |||||
| 3-Year EBITDA Growth Rate | 14.9 | |||||
| 3-Year FCF Growth Rate | 20.6 | |||||
| 3-Year Book Growth Rate | 3.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 76.28 | |||||
| 9-Day RSI | 65.27 | |||||
| 14-Day RSI | 58.66 | |||||
| 6-1 Month Momentum % | -27.5 | |||||
| 12-1 Month Momentum % | -50.85 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.49 | |||||
| Quick Ratio | 3.38 | |||||
| Cash Ratio | 1.78 | |||||
| Days Inventory | 42.76 | |||||
| Days Sales Outstanding | 34.89 | |||||
| Days Payable | 60.97 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -24.49 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.36 | |||||
| Operating Margin % | -11.95 | |||||
| Net Margin % | -224.82 | |||||
| FCF Margin % | -2.55 | |||||
| ROE % | -13.15 | |||||
| ROA % | -11.58 | |||||
| ROIC % | -0.86 | |||||
| ROC (Joel Greenblatt) % | -100.6 | |||||
| ROCE % | -10.48 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 0.8 | |||||
| Price-to-Owner-Earnings | 0.76 | |||||
| PS Ratio | 1.28 | |||||
| PB Ratio | 0.07 | |||||
| Price-to-Tangible-Book | 0.07 | |||||
| EV-to-EBIT | -0.72 | |||||
| EV-to-EBITDA | -0.72 | |||||
| EV-to-Revenue | 1.4 | |||||
| EV-to-FCF | -54.96 | |||||
| Price-to-Net-Current-Asset-Value | 3.2 | |||||
| Earnings Yield (Greenblatt) % | -138.89 | |||||
| FCF Yield % | -2.29 | |||||
| Forward Rate of Return (Yacktman) % | -1.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Extrawell Pharmaceutical Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 68.623 | ||
| EPS (TTM) (HK$) | -0.072 | ||
| Beta | 0.41 | ||
| Volatility % | 22.25 | ||
| 14-Day RSI | 58.66 | ||
| 14-Day ATR (HK$) | 0.002038 | ||
| 20-Day SMA (HK$) | 0.02775 | ||
| 12-1 Month Momentum % | -50.85 | ||
| 52-Week Range (HK$) | 0.026 - 0.065 | ||
| Shares Outstanding (Mil) | 2,390 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Extrawell Pharmaceutical Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Extrawell Pharmaceutical Holdings Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Extrawell Pharmaceutical Holdings Ltd Frequently Asked Questions
What is Extrawell Pharmaceutical Holdings Ltd(HKSE:00858)'s stock price today?
The current price of HKSE:00858 is HK$0.03. The 52 week high of HKSE:00858 is HK$0.07 and 52 week low is HK$0.03.
When is next earnings date of Extrawell Pharmaceutical Holdings Ltd(HKSE:00858)?
The next earnings date of Extrawell Pharmaceutical Holdings Ltd(HKSE:00858) is .
Does Extrawell Pharmaceutical Holdings Ltd(HKSE:00858) pay dividends? If so, how much?
Extrawell Pharmaceutical Holdings Ltd(HKSE:00858) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers